Solubility

(μg/mL)

Increased scavenging rate of DPPH free radical activity (%)

Increased antihemolytic activity (%)

T_max (min)

C_max (μg/mL)

Relative bioavail-ability

Hesperetin

23.78

-

-

180

0.47

-

Hesperetin-Caffeine

90.2

50

60

90

1.27

1.60

Hesperetin-Nicotinamide

94.02

30

40

90

1.15

1.57

Hesperetin-pyridine-2-carboxylic acid

68.54

20

30

120

0.63

1.36